Table 3. Median survival time and 1, 2, 3-year overall survival rates of patients in the training set and the validation set in this study.

	Training	set (n = 888)	Validation	set (n = 444)
	HALP < 56.8 (n = 618)	HALP ≥ 56.8 (n = 270)	HALP < 56.8 (n = 309)	HALP ≥ 56.8 (n = 135)
Median survival time (months)	67.7 (0.3–116.2)	108.0 (0.6–118.0)	68.8 (0.9–115.7)	108.0 (3.9–115.1)
1-year overall survival rates (%)	78.0	83.7	76.7	85.2
2-year overall survival rates (%)	67.1	78.8	66.9	79.2
3-year overall survival rates (%)	59.7	74.7	57.5	73.5

Abbreviations: HALP: Hemoglobin*Albumin*Lymphocyte/Platelet index.